Corbus Pharmaceuticals (CRBP) Financials: Revenue & Earnings

CRBP price $4.15 0.00 0.00%

Ticker
CRBP
Price
$4.15
Change
0.00 0.00%
Market cap ?
$80.27M
P/E ?
-0.64
Dividend yield ?
0.00%
Beta ?
2.63
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
69
Value
59
Quality
47
Growth
100

Stocklytics score rationale: value 59, quality 47, growth 100.

Financials

2016201720182019202020212022202320242025
1911424244019548222723614356839372308817050000

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells…

Fair value

CRBP fair value Not meaningful. Price $4.15.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare CRBP

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-1.21—2.00M
2026-08-06-1.81-1.26—1.11M
2026-05-12-1.23-1.26——
2026-03-09-1.25-1.78—1.67M
2025-11-12-1.90-1.80—1.11M
2025-08-05-1.44-1.55——
2025-05-06-1.39-1.26——
2025-03-11-0.78-1.02——
2024-11-07-1.15-0.99——
2024-08-06-0.90-1.16——
2024-05-07-0.83-1.09——
2024-03-12-1.81-2.361.35M—
2023-11-07-2.27-2.06——
2023-08-08-2.05-3.10——
2023-05-09-4.24-4.09——
2023-03-07-2.61-2.10——
2022-11-08-2.10-1.80——
2022-08-09-3.30-1.80—200.00K
2022-05-10-2.40-2.70—150.00K
2022-03-08-2.40-3.30-881.71K347.50K
2021-11-12-0.60-3.6097.32K610.00K
2021-08-12-4.50-3.60136.56K137.00K
2021-05-13-4.20-4.50647.82K691.01K
2021-03-15-3.00-6.61658.20K—
2020-11-10-12.91-12.311.23M—
2020-08-06-15.62-11.41286.35K214.76K
2020-05-11-12.91-12.911.76M1.64M
2020-03-12-12.31-10.212.57M2.26M
2019-11-07-9.61-10.812.59M3.08M
2019-08-080.90-10.6829.09M349.13M
2019-05-09-12.910.601.89M1.18M
2019-03-12-9.01-6.611.93M1.67M
2018-11-08-7.81-6.311.09M923.05K
2018-08-08-6.31-6.01853.65K853.65K
2018-05-10-6.31-2.40950.44K633.63K
2018-03-12-6.01-4.80-2.44M1.74B
2017-11-08-4.20-5.11796.31K910.07K
2017-08-09-4.50-5.71350.19K443.57K
2017-05-09-4.80-5.111.29M1.29M
2017-03-09-5.41-3.30375.67K250.45K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-14Ben YongSell2.00K$7.8415.68K
2026-08-16Nicacio Leonardo VianaBuy191.68K$10.091.93M
2026-08-16Nicacio Leonardo VianaBuy58.33K——
2026-08-11Saxena Nishant CBuy2.60K$9.6325.04K
2026-08-07Cohen YuvalSell17.00K$10.08171.40K
2026-08-07Moran Sean F.Sell12.00K$10.08120.97K
2026-08-03Nicacio Leonardo VianaOther0——
2026-06-10Kung WinstonSell2.03K$7.9116.03K
2026-06-10Altmeyer AnneSell2.41K$7.9119.09K
2026-06-10Jenkins John KennethSell4.80K$7.9137.99K
2026-06-03Saxena Nishant CBuy9.00K$7.5868.22K
2026-06-02Saxena Nishant CBuy4.50K$7.3333.00K
2026-05-21Saxena Nishant CBuy192.30K$11.512.21M
2026-05-21Saxena Nishant CBuy58.30K——
2026-05-21Saxena Nishant COther0——
2026-05-19Kung WinstonBuy3.80K——
2026-05-19Kung WinstonBuy12.30K$9.15112.55K
2026-05-19Jacques Rachelle SuzanneBuy12.30K$9.15112.55K
2026-05-19Jacques Rachelle SuzanneBuy3.80K——
2026-05-19Jenkins John KennethBuy12.30K$9.15112.55K
2026-05-19Jenkins John KennethBuy3.80K——
2026-05-19Altmeyer AnneBuy12.30K$9.15112.55K
2026-05-19Altmeyer AnneBuy3.80K——
2026-05-19Ben YongBuy12.30K$9.15112.55K
2026-05-19Ben YongBuy3.80K——
2026-05-19Pfeiffenberger BrentBuy24.70K$9.15226.00K
2026-05-19Pfeiffenberger BrentBuy7.50K——
2026-05-13Pfeiffenberger BrentOther0——
2026-03-02Smethurst DominicSell6.10K$8.3050.60K
2026-02-17Hodgson IanSell847$7.386.25K
2026-02-13Moran Sean F.Sell4.70K$7.7836.59K
2026-02-13Cohen YuvalSell13.87K$7.78107.95K
2026-02-03Smethurst DominicSell3.29K$8.0926.57K
2026-02-03Hodgson IanSell2.42K$8.0919.54K
2026-01-14Smethurst DominicBuy28.36K——
2026-01-14Smethurst DominicBuy85.09K$8.26702.88K
2026-01-14Moran Sean F.Buy28.08K——
2026-01-14Moran Sean F.Buy84.25K$8.26695.88K
2026-01-14Cohen YuvalBuy50.00K——
2026-01-14Cohen YuvalBuy150.00K$8.261.24M
2026-01-14Hodgson IanBuy85.09K$8.26702.88K
2026-01-14Hodgson IanBuy28.36K——
2025-12-11Cormorant Asset Management, LPSell30.03K$11.46344.01K
2025-10-27Cohen YuvalBuy8.97K$4.2638.22K
2025-10-27Cohen YuvalSell8.97K$17.14153.80K
2025-10-27Cohen YuvalSell8.97K$4.2638.22K
2025-10-24Cohen YuvalBuy18.66K$4.2679.49K
2025-10-24Cohen YuvalSell18.66K$17.01317.41K
2025-10-24Cohen YuvalSell18.66K$4.2679.49K
2025-10-24Moran Sean F.Buy12.98K$4.2655.30K
2025-10-24Moran Sean F.Sell12.98K$17.02220.94K
2025-10-24Moran Sean F.Sell12.98K$4.2655.30K
2025-10-20Altmeyer AnneBuy1.06K$4.805.09K
2025-10-20Altmeyer AnneSell1.06K$20.5021.73K
2025-10-20Altmeyer AnneSell1.06K$4.805.09K
2025-05-30Kung WinstonBuy16.00K$7.42118.72K
2025-05-30Kung WinstonBuy4.80K——
2025-05-30Jenkins John KennethBuy16.00K$7.42118.72K
2025-05-30Jenkins John KennethBuy4.80K——
2025-05-30Jenkins John KennethSell2.78K$7.3520.47K
2025-05-30Ben YongBuy16.00K$7.42118.72K
2025-05-30Ben YongBuy4.80K——
2025-05-30Altmeyer AnneBuy16.00K$7.42118.72K
2025-05-30Altmeyer AnneBuy4.80K——
2025-05-30Altmeyer AnneSell1.39K$7.2510.10K
2025-05-30HOLMER ALAN FBuy16.00K$7.42118.72K
2025-05-30HOLMER ALAN FBuy4.80K——
2025-05-30Jacques Rachelle SuzanneBuy16.00K$7.42118.72K
2025-05-30Jacques Rachelle SuzanneBuy4.80K——
2025-03-13Hodgson IanOther0——
2025-03-13Hodgson IanOther0——
2025-03-13Hodgson IanOther1.99K$4.268.46K
2025-03-13Hodgson IanOther60.00K$9.79587.40K
2025-03-13Hodgson IanOther5.00K$23.10115.50K
2025-03-13Hodgson IanOther3.33K$3.8112.70K
2025-03-06Smethurst DominicSell6.39K$6.7843.33K
2025-02-14Moran Sean F.Sell2.79K$8.7624.45K
2025-02-14Cohen YuvalSell7.13K$8.7662.46K
2025-01-31Smethurst DominicBuy91.20K$9.79892.85K
2025-01-31Smethurst DominicBuy27.20K——
2025-01-31Moran Sean F.Buy92.50K$9.79905.57K
2025-01-31Moran Sean F.Buy27.50K——
2025-01-31Cohen YuvalBuy228.80K$9.792.24M
2025-01-31Cohen YuvalBuy68.10K——
2024-09-20Cormorant Asset Management, LPBuy25.77K$22.23572.79K
2024-09-20Cormorant Asset Management, LPBuy47.56K$21.471.02M
2024-09-20Cormorant Asset Management, LPBuy139.55K$20.422.85M
2024-09-20Cormorant Asset Management, LPBuy66.09K$19.611.30M
2024-09-20Cormorant Asset Management, LPBuy25.94K$18.36476.31K
2024-09-20Cormorant Asset Management, LPBuy45.09K$17.48787.86K
2024-08-16Kung WinstonBuy5.57K$53.52297.89K
2024-08-16Kung WinstonBuy5.57K——
2024-08-16Kung WinstonOther0——
2024-06-18Moran Sean F.Buy1.96K$30.0058.74K
2024-06-18Moran Sean F.Sell1.96K$42.1282.48K
2024-06-18Moran Sean F.Sell1.96K$30.0058.74K
2024-06-18Cohen YuvalBuy11.67K$30.00350.01K
2024-06-18Cohen YuvalBuy2.32K$4.269.89K
2024-06-18Cohen YuvalBuy1.77K$14.1024.96K
2024-06-18Cohen YuvalSell2.32K$42.2498.07K

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

Corbus Pharmaceuticals Holdings, Inc. (CRBP) trades at $4.15, with a market cap of $80.27M and a trailing P/E of -0.64. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
1911424244019548222723614356839372308817050000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Corbus Pharmaceuticals (CRBP) Financials: Revenue & Earnings

CRBP$4.150.00 0.00%

$80.27M

Market Cap

-0.64

P/E

—

Forward P/E

69

Score

Price History